VYNE Therapeutics Inc.

VYNE

—

Advanced chart & tools →

VYNE Therapeutics Inc.VYNE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.62

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$570,000

Net income

$-26.48M

Net margin

-4646.1%

Gross margin

—

Dividends & financials

VYNE Therapeutics Inc. (VYNE) reported revenue of $570,000 and net income of $-26.48M, or $-0.62 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.